Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 932.6K | $8.0M | 9.96% | -250.0K | 2026-06-30 |
| ORBIMED ADVISORS LLC | 844.8K | $7.0M | 9.02% | -183.2K | 2026-06-30 |
| FRANKLIN RESOURCES INC | 626.6K | $5.0M | 6.69% | -- | 2026-06-30 |
| CITADEL ADVISORS LLC | 466.2K | $4.0M | 4.98% | +84.4K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 343.2K | $2.0M | 3.67% | +6.7K | 2026-06-30 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 274.4K | $2.0M | 2.93% | -- | 2026-06-30 |
| RENAISSANCE TECHNOLOGIES LLC | 265.9K | $2.0M | 2.84% | +33.4K | 2026-06-30 |
| Stonepine Capital Management, LLC | 245.5K | $2.0M | 2.62% | +23.6K | 2026-06-30 |
| Alyeska Investment Group, L.P. | 203.8K | $1.0M | 2.18% | -- | 2026-06-30 |
| Schonfeld Strategic Advisors LLC | 195.5K | $1.0M | 2.09% | -- | 2026-06-30 |
